Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
576.41
+16.88 (3.02%)
At close: Jul 28, 2026, 4:00 PM EDT
574.42
-1.99 (-0.35%)
After-hours: Jul 28, 2026, 7:59 PM EDT

Thermo Fisher Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Revenue
11,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,7029,330
Revenue Growth (YoY)
10.49%6.19%7.20%4.94%2.98%0.18%4.68%0.23%-1.37%-3.41%-4.93%-0.97%-2.58%-9.38%6.99%14.44%18.30%19.30%1.44%9.49%
Cost of Revenue
7,0516,5757,2046,5396,4466,1296,5736,2706,1946,1406,4936,2586,4366,5706,8446,3756,3716,3545,4484,679
Gross Profit
4,9434,4305,0114,5834,4094,2354,8224,3284,3474,2054,3934,3164,2514,1404,6064,3024,5995,4645,2544,651
Selling, General & Admin
1,9092,1812,3522,1622,1402,0782,2032,0982,1112,1832,1322,0492,1452,1192,2992,2082,2092,2772,2782,004
Depreciation & Amortization Expenses
485-------------------
Research & Development
364336356346352342374346339331327319345346391351365364392351
Other Operating Expenses
9849461358298228457729808418311255332424618
Total Operating Expenses
2,8562,5662,7542,6432,5742,5182,8052,4892,5272,5432,5392,4522,6732,5772,7452,5922,5982,6432,7162,373
Operating Income
2,0871,8632,2551,9411,8341,7162,0161,8381,8201,6631,8541,8641,5781,5631,8611,7102,0012,8212,5382,278
Interest Income
207233258234297203227277295279309246178146150683618119
Interest Expense
-401-354-365-347-404-303-317-356-354-363-390-359-326-300-269-173-148-136-161-128
Other Non-Operating Income (Expense)
31-96-2-19314-16510-3314--4635-428-163-52618
Total Non-Operating Income (Expense)
-163-130-101-115-126-97-76-95-54-74-114-99-148-200-84-109-84-281-676-101
Pretax Income
1,9241,7342,1531,8261,7091,6201,9411,7421,7651,5891,7401,7651,4301,3631,7771,6011,9172,5401,8622,177
Provision for Income Taxes
1677015320792951509912828113353524617331198301203271
Net Income
1,7571,6642,0001,6191,6171,5251,7911,6431,6371,3081,6071,7121,3781,3171,6041,5701,7192,2391,6591,906
Minority Interest in Earnings
2013383018-391490-19-23-317282875552414
Net Income to Common
1,7361,6511,9641,6161,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,4951,6642,2151,6581,902
Net Income Growth (YoY)
7.36%9.55%7.32%-0.86%4.46%13.48%12.27%-4.96%13.74%3.03%3.43%14.72%-18.21%-41.81%-4.95%-21.40%-8.97%-5.22%-33.76%-1.60%
Shares Outstanding (Basic)
371372376378378378382382382382387386386386391392392392394394
Shares Outstanding (Diluted)
371373377378378379383384383384388388388388393395394395398397
Shares Change (YoY)
-1.85%-1.58%-1.57%-1.56%-1.31%-1.30%-1.29%-1.03%-1.29%-1.03%-1.27%-1.77%-1.52%-1.77%-1.26%-0.50%-0.51%-0.50%-0.50%-0.50%
EPS (Basic)
4.684.445.224.284.283.994.794.264.053.474.224.443.533.344.033.824.255.664.204.83
EPS (Diluted)
4.684.435.214.274.283.984.784.254.043.464.204.423.513.324.013.794.225.614.174.79
EPS Growth (YoY)
9.35%11.31%9.00%0.47%5.94%15.03%13.81%-3.85%15.10%4.22%4.74%16.62%-16.83%-40.82%-3.84%-20.88%-8.46%-4.59%-33.17%-1.03%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Free Cash Flow
1,6758162,9921,8351,1053612,8101,8941,6599043,3182,0821,2562712,9371,3901,0221,5621,6262,126
Free Cash Flow Growth (YoY)
51.58%126.04%6.48%-3.12%-33.39%-60.07%-15.31%-9.03%32.09%233.58%12.97%49.78%22.90%-82.65%80.63%-34.62%-39.42%15.70%-40.94%-9.22%
Free Cash Flow Per Share
4.512.197.944.852.920.957.344.934.332.358.555.373.240.707.473.522.593.954.095.36
Dividends Per Share
-0.4700.4300.4300.4300.4300.3900.3900.3900.3900.3500.3500.3500.3500.3000.3000.3000.3000.2600.260
Dividend Growth (YoY)
-9.30%10.26%10.26%10.26%10.26%11.43%11.43%11.43%11.43%16.67%16.67%16.67%16.67%15.38%15.38%15.38%15.38%18.18%18.18%
Gross Margin
41.21%40.25%41.02%41.21%40.62%40.86%42.32%40.84%41.24%40.65%40.35%40.82%39.78%38.66%40.23%40.29%41.92%46.23%49.09%49.85%
Operating Margin
17.40%16.93%18.46%17.45%16.90%16.56%17.69%17.34%17.27%16.08%17.03%17.63%14.77%14.59%16.25%16.02%18.24%23.87%23.72%24.42%
Profit Margin
14.65%15.12%16.37%14.56%14.90%14.71%15.72%15.50%15.53%12.64%14.76%16.19%12.89%12.30%14.01%14.70%15.67%18.95%15.50%20.43%
FCF Margin
13.97%7.41%24.49%16.50%10.18%3.48%24.66%17.87%15.74%8.74%30.48%19.69%11.75%2.53%25.65%13.02%9.32%13.22%15.19%22.79%
EBITDA
2,0872,5992,9832,6022,5202,4212,7582,5772,6112,4992,6932,7172,4332,4222,7092,5482,8373,6803,2212,906
EBITDA Margin
17.40%23.62%24.42%23.40%23.22%23.36%24.20%24.32%24.77%24.16%24.74%25.70%22.77%22.61%23.66%23.86%25.86%31.14%30.10%31.15%
EBIT
2,0871,8632,2551,9411,8341,7162,0161,8381,8201,6631,8541,8641,5781,5631,8611,7102,0012,8212,5382,278
EBIT Margin
17.40%16.93%18.46%17.45%16.90%16.56%17.69%17.34%17.27%16.08%17.03%17.63%14.77%14.59%16.25%16.02%18.24%23.87%23.72%24.42%
Effective Tax Rate
8.68%4.04%7.11%11.34%5.38%5.86%7.73%5.68%7.25%17.68%7.64%3.00%3.64%3.37%9.74%1.94%10.33%11.85%10.90%12.45%
SEC Filings: 10-K · 10-Q